| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : 2007 : ASCO 2007 : Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for Hepatoprotective Effect of Dexamethasone on Transient Transaminitis After Trabectedin (ET-743, Yondelis®) Treatment | published Mon, Nov 10, 2008 - 15:27 EST |
Cognigen's Primary Author: G. Fetterly, Johnson & Johnson Primary Author: K. Stuyckens
Primary Authors: Gerald Fetterly, Cognigen Corporation, Buffalo, NY, Kim Stuyckens, Johnson & Johnson Pharmaceutical Research & Development, Belgium
Event: 43rd ASCO Annual Meeting, Chicago, IL, June 1-5, 2007
Johnson & Johnson Contributing Authors:
P. Zanniokos
Juan Jose Perez Ruixo
PharmaMar Contributing Authors:
Arturo Soto-Matos
Miguel Angel Izuierdo
Cognigen Corporation Contributing Authors:
Joel Owen
Julie Passarell
| Cognigen Corporation - Posters and Presentations : 2007 : ASCO 2007 : Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for Hepatoprotective Effect of Dexamethasone on Transient Transaminitis After Trabectedin (ET-743, Yondelis®) Treatment | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |